UCL HUNTINGTON’S DISEASE RESEARCH

INFORMATION FOR SCIENTISTS, CLINICIANS, PATIENTS, RELATIVES AND CARERS

UCL HUNTINGTON’S DISEASE RESEARCH

NEUROENDOCRINE STUDY OF HD

*PLEASE NOTE THIS STUDY IS NOW FULLY RECRUITED*

At a glance

Involves blood tests
Involve an MRI brain scan

About the study

Neuroendocrine HD aims to examine changes in hormones and metabolic factors at different stages of HD. Previous studies suggest that some features of HD including weight loss, sleep disturbances, mood changes and muscle loss may be caused by disruption of neuroendocrine systems.
This study hopes to identify potential biomarkers to monitor disease state and progression, which may represent targets for future clinical trials.

What is involved

Neuroendocrine HD involves a single visit to the Royal Free Hospital for a period of 24 hours (overnight stay in a private suite).  The tests performed include a clinical examination, blood and urine tests, and a magnetic resonance (MRI) scan of the abdomen.

Who can take part

Neuroendocrine HD aims to recruit:
We are currently looking for volunteers from all of these groups so if you are interested in taking part or to find out more, please feel free to contact the study team.
Contact the study team for more information:

Professor Tom Warner (Consultant Neurologist)
Royal Free Hospital, Pond Street
London NW3 2PF
twarner@medsch.ucl.ac.uk
Updated February 14, 2013